Does sapropterin work for all pku patients?

Does sapropterin work for all PKU patients?

Sapropterin helps some but not all patients with phenylketonuria (PKU). It lowers phenylalanine levels in roughly 20 to 30 percent of cases.

Does sapropterin work on every type of PKU?

It works only in patients with residual phenylalanine hydroxylase (PAH) activity. Complete enzyme absence means sapropterin has no effect.

How do doctors test if sapropterin works for einen patient?

A blood phenylalanine test taken before and after a short trial shows whether the drug lowers levels. A 30 percent drop confirms response.

What happens if sapropterin fails?

Patients who do not respond continue strict low-phenylalanine diets indefinitely. They may also join clinical trials for new therapies such as gene therapy or enzyme replacement.

Can other drugs compete with sapropterin?

Pegvaliase is an enzyme replacement therapy that works in adults regardless of PAH activity. It requires weekly injections and carries risk of severe allergic reactions.

When does the sapropterin patent expire?

The primary compound patent for sapropterin expired in 2017. Generic versions entered the market afterward.